HIND
Price
$7.99
Change
+$0.04 (+0.50%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
213.32M
PTNTD
Price
$9.00
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
N/A
28 days until earnings call
Interact to see
Advertisement

HIND vs PTNTD

Header iconHIND vs PTNTD Comparison
Open Charts HIND vs PTNTDBanner chart's image
Vyome Holdings
Price$7.99
Change+$0.04 (+0.50%)
Volume$100
Capitalization213.32M
Palatin Technologies
Price$9.00
Change-$0.00 (-0.00%)
Volume$1.18K
CapitalizationN/A
HIND vs PTNTD Comparison Chart in %
Loading...
HIND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTNTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HIND vs. PTNTD commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIND is a Hold and PTNTD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (HIND: $7.95 vs. PTNTD: $9.00)
Brand notoriety: HIND and PTNTD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HIND: 4% vs. PTNTD: 0%
Market capitalization -- HIND: $213.32M vs. PTNTD: $0
HIND [@Biotechnology] is valued at $213.32M. PTNTD’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIND’s FA Score shows that 0 FA rating(s) are green whilePTNTD’s FA Score has 1 green FA rating(s).

  • HIND’s FA Score: 0 green, 5 red.
  • PTNTD’s FA Score: 1 green, 4 red.
According to our system of comparison, PTNTD is a better buy in the long-term than HIND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIND’s TA Score shows that 5 TA indicator(s) are bullish while PTNTD’s TA Score has 4 bullish TA indicator(s).

  • HIND’s TA Score: 5 bullish, 5 bearish.
  • PTNTD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HIND is a better buy in the short-term than PTNTD.

Price Growth

HIND (@Biotechnology) experienced а -13.59% price change this week, while PTNTD (@Biotechnology) price change was -11.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

PTNTD is expected to report earnings on Oct 07, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTNTD YTD gains are higher at: 710.811 vs. HIND (78.251).
HINDPTNTDHIND / PTNTD
Capitalization213MN/A-
EBITDAN/AN/A-
Gain YTD78.251710.81111%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
HIND vs PTNTD: Fundamental Ratings
HIND
PTNTD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7523

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTNTD's Valuation (5) in the null industry is significantly better than the same rating for HIND (73). This means that PTNTD’s stock grew significantly faster than HIND’s over the last 12 months.

PTNTD's Profit vs Risk Rating (100) in the null industry is in the same range as HIND (100). This means that PTNTD’s stock grew similarly to HIND’s over the last 12 months.

PTNTD's SMR Rating (100) in the null industry is in the same range as HIND (100). This means that PTNTD’s stock grew similarly to HIND’s over the last 12 months.

PTNTD's Price Growth Rating (34) in the null industry is in the same range as HIND (34). This means that PTNTD’s stock grew similarly to HIND’s over the last 12 months.

PTNTD's P/E Growth Rating (100) in the null industry is in the same range as HIND (100). This means that PTNTD’s stock grew similarly to HIND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HINDPTNTD
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 18 days ago
87%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 6 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HIND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTNTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA350.8412.31
+3.64%
Tesla
GME22.610.24
+1.07%
GameStop Corp
BTC.X111167.620000942.921900
+0.86%
Bitcoin cryptocurrency
AAPL239.69-0.09
-0.04%
Apple
SPY647.24-1.88
-0.29%
SPDR® S&P 500® ETF

HIND and

Correlation & Price change

A.I.dvisor tells us that HIND and WVE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIND and WVE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIND
1D Price
Change %
HIND100%
+2.19%
WVE - HIND
32%
Poorly correlated
+1.34%
AIM - HIND
3%
Poorly correlated
+1.64%
LIMN - HIND
2%
Poorly correlated
-5.65%
YDES - HIND
2%
Poorly correlated
+5.74%
PTNTD - HIND
1%
Poorly correlated
N/A
More

PTNTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTNTD has been loosely correlated with ETHZ. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTNTD jumps, then ETHZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTNTD
1D Price
Change %
PTNTD100%
N/A
ETHZ - PTNTD
41%
Loosely correlated
-4.55%
XFOR - PTNTD
33%
Loosely correlated
-3.85%
ARCT - PTNTD
32%
Poorly correlated
+6.50%
CLDX - PTNTD
26%
Poorly correlated
+0.40%
MRVI - PTNTD
22%
Poorly correlated
+6.36%
More